Author Archives: admin

TcLand Expression will receive 1.2 million Euros from Oseo and ERDF to support a leading project in personalised medicine focused on Rheumatoid Arthritis

The biotech company TcLand Expression is pleased to announce the financial support awarded by Oseo and the European Regional Development Fund (ERDF) for the validation study of the first companion diagnostic test in rheumatoid arthritis. The program is mainly dedicated … Continue reading

Posted in Business / Finance | Comments Off on TcLand Expression will receive 1.2 million Euros from Oseo and ERDF to support a leading project in personalised medicine focused on Rheumatoid Arthritis

TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member

TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine today announced the appointment of Felix Frueh PhD, as new member of the company’s Board of Directors. EN. TcLand Expression SA, société leader dans le … Continue reading

Posted in Corporate | Comments Off on TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member

TcLand Expression is part of the Innovative Medicines Initiative “Be The CURE”, the largest European consortium for Rheumatology

TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine, today is pleased to announce its participation in the Innovative Medicines Initiative (IMI) project “Be The CURE”.EN. TcLand Expression est heureux d’annoncer sa participation au projet “Be The Cure”, … Continue reading

Posted in R&D / Quality | Comments Off on TcLand Expression is part of the Innovative Medicines Initiative “Be The CURE”, the largest European consortium for Rheumatology

TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient

TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient TcLand Expression annonce la mise en place de « PRINT », étude clinique internationale de validation de son … Continue reading

Posted in R&D / Quality | Comments Off on TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient

TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition

TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition TcLand Expression distinguée comme membre emblématique de la “Personalized Medicine Coalition”

Posted in Uncategorized | Comments Off on TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition

Scientific and Medical Advisory Board dedicated to Rheumatology

TcLand Expression appoints its Scientific and Medical Advisory Board dedicated to Rheumatology TcLand Expression annonce la création de son Conseil Scientifique et Médical dédié à la rhumatologie

Posted in R&D / Quality | Comments Off on Scientific and Medical Advisory Board dedicated to Rheumatology

Peter Payne appointed as Chief Business Officer and Head of US Operations

TcLand Expression strengthens its senior management team by appointing Peter Payne as Chief Business Officer and Head of US Operations. TcLand Expression renforce son équipe dirigeante senior avec la nomination de Peter Payne en tant que Directeur du Business Développement … Continue reading

Posted in Corporate | Comments Off on Peter Payne appointed as Chief Business Officer and Head of US Operations

First EPEMED conference

EPEMED, European personalized medicine Association organized its first conference in Paris. FR.

Posted in Corporate | Comments Off on First EPEMED conference

Licensing agreement with Inserm Transfert

TcLand Expression signs a licensing agreement with Inserm Transfert and initiates a strategic collaboration on the development of companion diagnostic tests for rheumatoid arthritis therapies. EN. FR.

Posted in Business / Finance | Comments Off on Licensing agreement with Inserm Transfert

Major new partnership with research institute

TcLand Expression initiates major partnership with the Hospital Vall d’Hebron Research Institute and gets exclusive rights on key intellectual property in the field of novel biomarkers in rheumatoid arthritis. EN. FR.

Posted in R&D / Quality | Comments Off on Major new partnership with research institute